[Cytoprotection: a new principle in ulcer therapy?].
D001241:Aspirin / Q000009:adverse effects; D002229:Carbenoxolone / Q000627:therapeutic use; D002927:Cimetidine / Q000627:therapeutic use; D005753:Gastric Mucosa / Q000187:drug effects*; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects; D010437:Peptic Ulcer / Q000188:drug therapy*; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use
D011465:Prostaglandins, Synthetic; D002927:Cimetidine; D002229:Carbenoxolone; D001241:Aspirin; D007213:Indomethacin
Zytoprotektion: ein neues Prinzip in der Ulkustherapie?